Clinical trial

HER2 PET Imaging in Breast Cancer Patients Using [68GA]ABY-025

NCT02095210

StatusTERMINATED

Study typeINTERVENTIONAL

Start date2011-08-01

PhasePHASE1

Study timeline

Study start (actual)2011-08-01Date precision: month

Registry last updated2020-10-05

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

HER2-positive Breast Cancerunresolved

Interventions

Radiolabeled [68Ga]ABY-025OTHER

Sponsors & collaborators

Dorte Nielsenlead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02095210 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.